In pancreatic cancer, HNF1A was shown to transcriptionally activate 53BP1 expression, with its expression negatively correlated with oxaliplatin chemoresistance in pancreatic ductal carcinoma (PDAC) tissues and cell lines. Here, HNF1A is linked to pancreatic ductal adenocarcinoma.